Press Releases Our top headlines making news around the world BlogPress Releases SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 READ MORE SOPHiA GENETICS Announces Poster Presentations at ESMO 2024 READ MORE SOPHiA GENETICS Announces Updates on SOPHiA UNITY at ESMO 2024 READ MORE SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing READ MORE SOPHiA GENETICS Announces It Joins the European Liquid Biopsy Society at ECP 2024 READ MORE SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 READ MORE SOPHiA GENETICS Unveils New Generation of the SOPHiA DDM™ Platform at Morgan Stanley Healthcare Conference 2024 READ MORE SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference READ MORE SOPHiA DDM™ Platform Certified Under IVDR READ MORE SOPHiA GENETICS Reports Second Quarter 2024 Results READ MORE SOPHiA GENETICS Announces L’hôpital Universitaire Avicenne is Live on SOPHiA DDM™ READ MORE SOPHiA GENETICS Announces Expanded Relationship with Canada-Based OncoHelix READ MORE « Older Entries Want to know more? Get in touch with us. Our client services team is on hand to help. First Name(Required) Last Name(Required) Institution(Required) Job Title/Industry(Required)RoleArtificial Intelligence/Machine LearningBiomarkers and DiagnosticsBusiness, Strategy, and InnovationClinical OperationsData ScienceDepartment HeadExecutive/Corporate ManagementGenetics CounselorHospital ManagementLab Manager/DirectorMedical AffairsPartner/DistributorPathologistPharmaceutical/CROPhysician/ClinicianR&DRWD/RWEScientist/ResearcherStudentOtherArea of Interest(Required)Area of InterestsAdministrativeAlamut Visual PlusBioPharma CollaborationBlood CancersData AccessData AnalyticsHereditary CancersLIMS/EHR integrationLiquid BiopsyMultimodal applicationsRare and Inherited DiseaseSmart DiagnosticsSolid TumorsSophia DDM PlatformOtherEmail(Required) Phone(Required)Country(Required)Select CountryAfghanistanAland IslandsAlbaniaAlgeriaAndorraAngolaAnguillaAntarcticaAntigua and BarbudaArgentinaArmeniaArubaAustralia*AustriaAzerbaijanBahamasBahrainBangladeshBarbadosBelarusBelgiumBelizeBeninBermudaBhutanBolivia, Plurinational State ofBonaire, Sint Eustatius, and SabaBosnia and HerzegovinaBotswanaBouvet IslandBrazil*British Indian Ocean TerritoryBrunei DarussalamBulgariaBurkina FasoBurundiCambodiaCameroonCanada*Cape VerdeCayman IslandsCentral African RepublicChadChileChina*Christmas IslandCocos (Keeling) IslandsColombiaComorosCongoCongo, the Democratic Republic of theCook IslandsCosta RicaCroatiaCubaCuraçaoCyprusCzechiaDenmarkDjiboutiDominicaDominican RepublicEcuadorEgyptEl SalvadorEquatorial GuineaEritreaEstoniaEswatiniEthiopiaFalkland Islands (Malvinas)Faroe IslandsFijiFinlandFranceFrench GuianaFrench PolynesiaFrench Southern TerritoriesGabonGambiaGeorgiaGermanyGhanaGibraltarGreeceGreenlandGrenadaGuadeloupeGuatemalaGuernseyGuineaGuinea-BissauGuyanaHaitiHeard and McDonald IslandsHoly See (Vatican City State)HondurasHungaryIcelandIndia*IndonesiaIran, Islamic Republic ofIraqIreland*Isle of ManIsraelItaly*JamaicaJapanJerseyJordanKazakhstanKenyaKiribatiKorea, Democratic People’s Republic ofKorea, Republic ofKosovoKuwaitKyrgyzstanLao People's Democratic RepublicLatviaLebanonLesothoLiberiaLibyaLiechtensteinLithuaniaLuxembourgMacaoMadagascarMalawiMalaysiaMaldivesMaliMaltaMartiniqueMauritaniaMauritiusMayotteMexico*Moldova, Republic ofMonacoMongoliaMontenegroMontserratMoroccoMozambiqueMyanmarNamibiaNauruNepalNetherlandsNew CaledoniaNew ZealandNicaraguaNigerNigeriaNiueNorfolk IslandNorth MaceedoniaNorwayOmanPakistanPalestinePanamaPapua New GuineaParaguayPeruPhilippinesPitcairnPolandPortugalQatarRomaniaRussian FederationRwandaSaint BarthélemySaint Helena, Ascension and Tristan da CunhaSaint Kitts and NevisSaint LuciaSaint Martin (French part)Saint Pierre and MiquelonSaint Vincent and the GrenadinesSamoaSan MarinoSao Tome and PrincipeSaudi ArabiaSenegalSerbiaSeychellesSierra LeoneSingaporeSint Maarten (Dutch part)SlovakiaSloveniaSolomon IslandsSomaliaSouth AfricaSouth Georgia and the South Sandwich IslandsSouth SudanSpainSri LankaSudanSurinameSvalbard and Jan Mayen IslandsSwedenSwitzerlandSyrian Arab RepublicTaiwanTajikistanTanzania, United Republic ofThailandTimor-LesteTogoTokelauTongaTrinidad and TobagoTunisiaTürkiyeTurkmenistanTurks and Caicos IslandsTuvaluUgandaUkraineUnited Arab EmiratesUnited KingdomUnited States*UruguayUzbekistanVanuatuVenezuela, Bolivarian Republic ofVietnamVirgin Islands, BritishWallis and FutunaWestern SaharaYemenZambiaZimbabweSelect US StateSelect StateALAKAZARCACOCTDEDCFLGAHIIDILINIAKAKYLAMEMDMAMIMNMSMOMTNENVNHNJNMNYNCNDOHOKORPARISCSDTNTXUTVTVAWAWVWIWYCity Select ProvinceSelect ProvinceAlberta, CABritish Columbia, CAManitoba, CANew Brunswick, CANewfoundland and Labrador, CANorthwest Territories, CANova Scotia, CANunavut, CAOntario, CAPrince Edward Island, CAQuebec, CASaskatchewan, CAYukon, CAContact Reason(Required)Contact ReasonInformation on our solutionsRequest a demoMediaCareersSpeak to SalesType Your Message(Required)Privacy Policy(Required) By checking this box, I declare that I have read and accepted in full SOPHiA GENETICS privacy policy. The data provided herein is used to process your request. Click here for more information relating to our privacy policy Marketing Opt-In I agree to receive information from SOPHiA GENETICS about products, services, events and promotions. I understand I will be able unsubscribe by using the link integrated with the communication at any time. CAPTCHAEmailThis field is for validation purposes and should be left unchanged.
SOPHiA GENETICS Presents Ground-Breaking Multimodal Research on AI-Driven Patient Stratification at ESMO 2024 READ MORE
SOPHiA GENETICS and AstraZeneca Collaborate to Further Expand Global Access to Liquid Biopsy Testing READ MORE
SOPHiA GENETICS Announces Validation of Novel Clinical Trial Assay Together with Precision for Medicine at World Clinical Biomarkers & CDx 2024 READ MORE
SOPHiA GENETICS Unveils New Generation of the SOPHiA DDM™ Platform at Morgan Stanley Healthcare Conference 2024 READ MORE
SOPHiA GENETICS to Present at the 22nd Annual Morgan Stanley Healthcare Conference and 9th Annual TD Cowen FutureHealth Conference READ MORE